Clinical Trials · NCT05788965

Semaglutide in CFRD

CompletedPhase 2/Phase 3Semaglutide (Approved)
Phase
Phase 2/Phase 3
Recruitment status
Completed
Sponsor
University of Minnesota
Enrollment
8
Start date
Oct 2023
Locations
1 site, United States
Primary endpoint
Weight
View Semaglutide compound reference